Information de reference pour ce titreAccession Number: | 00004696-200504000-00026.
|
Author: | Chim, C-S 1; Ma, E S K 2; Loong, F 2; Kwong, Y-L 1
|
Institution: | (1)University Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, China (2)University Department of Pathology, Queen Mary Hospital
|
Title: | Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement.[Report]
|
Source: | Journal of Clinical Pathology. 58(4):443-445, April 2005.
|
Abstract: | Natural killer (NK) cell lymphomas are rare, and atypical features might lead to diagnostic pitfalls. This report describes an unusual patient in whom lymphoma occurred initially as isolated lymph node involvement, an exceptional presentation of an almost exclusively extranodal disease. Furthermore, during the terminal haemophagocytosis in the bone marrow, lymphoma cells lost the expression of the NK cell marker, CD56, making the histopathological diagnosis of bone marrow involvement difficult. This was resolved by in situ hybridisation for Epstein-Barr virus encoded small RNA, which detected occult bone marrow infiltration.
(C) 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists
|
Author Keywords: | CD56; Epstein-Barr virus encoded early small RNA; natural killer cell lymphoma; nodal.
|
References: | 1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting. J Clin Oncol 1999;17:3835-49.
2. Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: clinicopathologic and molecular features. Histol Histopathol 2002;17:539-54.
3. Kwong YL, Chan AC, Liang RH. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol 1997;15:71-9.
4. Chim CS, Ma SK, Au WY, et al. Nasal NK-cell lymphoma: long-term treatment outcome and validity of the IPI index. Blood 2004;103:216-21.
5. Jaffe ES, Chan JKC, Su IH, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphoma. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11.
6. Chim CS, Ooi GC, Shek WH, et al. Lethal midline granuloma revisited: nasal T/NK cell lymphoma. J Clin Oncol 1999;17:1322-5.
7. Chim CS, Shek TW, Ho J, et al. Primary CD56+ gastrointestinal lymphoma. Cancer 2001;91:525-33.
8. Chan JKC, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-13.
9. Chim CS, Au WY, Loong F, et al. Primary NK-cell lymphoma of the skeletal muscle. Histopathology 2002;41:371-4.
10. Kwong YL, Chan ACL, Liang R, et al. CD56+ NK lymphoma: two distinct subtypes with different clinicopathologic features and prognosis. Br J Haematol 1997;97:821-9.
11. Au WY, Pang A, Choy C, et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004;104:243-9.
12. Kagami Y, Suzuki R, Taji H, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999;23:1184-200.
13. Siu LL, Chan JK, Wong KF, et al. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas. Br J Haematol 2003;122:70-7.
14. Wong KF, Chan JK, Cheung MM, et al. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon. Am J Clin Pathol 2001;115:266-70.
|
Language: | English.
|
Document Type: | CASE REPORT.
|
Journal Subset: | Clinical Medicine. Behavioral & Social Sciences.
|
ISSN: | 0021-9746
|
NLM Journal Code: | ht3, 0376601
|
Annotation(s) | |